Whether mid-stage nasopharyngeal cancer patients need chemotherapy or not depends on the specific condition of the patients, individual physique and other factors, but at present, the main treatment method for mid-stage nasopharyngeal cancer is radiotherapy.
Intermediate stage nasopharyngeal cancer means that the patient may have already had peripheral lymph node metastasis, and the treatment method in this period is mainly radiotherapy, and some intermediate stage nasopharyngeal cancer patients with poor prognostic factors need to be treated with radiotherapy combined with chemotherapy, and in addition, some intermediate stage nasopharyngeal cancer patients who meet the corresponding conditions can be treated with targeted therapy.
Therefore, it is necessary to decide whether chemotherapy is needed and formulate individualized treatment plan for patients depending on their specific conditions and physical fitness, etc. Chemotherapy drugs commonly used in chemotherapy for nasopharyngeal cancer patients include docetaxel, cisplatin, gemcitabine, etc., which are prescription drugs and need to be used under strict guidance of physicians.
It is suggested that patients with mid-stage nasopharyngeal cancer should go to oncology department, head and neck surgery department, ear, nose and throat department of regular hospitals for relevant standardized treatment consultation.